Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal’s Health CareBOM:544350 +0.12%17 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:544350 with a GF Score™ of 17/100. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Dr Agarwal’s Health Care ranks better than 57.06% on this metric.
The historical rank and industry rank for Dr Agarwal’s Health Care's FCF Margin % or its related term are showing as below:
BOM:544350'
s FCF Margin % Range Over the Past 10 Years
Min: 2.12 Med: 7.41 Max: 13.48
Current: 2.81
During the past 5 years, the highest FCF Margin % of Dr Agarwal’s Health Care was 13.48%. The lowest was 2.12%. And the median was 7.41%.
BOM:544350's FCF Margin % is ranked better than 57.06% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs BOM:544350: 2.81
Dr Agarwal’s Health Care FCF Margin % Related Terms
Dr Agarwal’s Health Care FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544350 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Dr Agarwal’s Health Care's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal’s Health Care FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dr Agarwal’s Health Care's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Dr Agarwal’s Health Care's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal’s Health Care (BOM:544350) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dr Agarwal’s Health Care and its competitors. Over the past decade, Dr Agarwal’s Health Care's FCF Margin % has ranged from 2.12 to 13.48. According to the industry distribution chart, Dr Agarwal’s Health Care ranks #350 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 42.9%.
Is Dr Agarwal’s Health Care's FCF Margin % too high?
Dr Agarwal’s Health Care's current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 2.12 to a high of 13.48. Based on the distribution chart, Dr Agarwal’s Health Care ranks #350 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dr Agarwal’s Health Care has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal’s Health Care's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Dr Agarwal’s Health Care ranks #350 out of 815 companies for FCF Margin %. This puts Dr Agarwal’s Health Care in the upper half of its industry. Historically, Dr Agarwal’s Health Care's own FCF Margin % has ranged from 2.12 to 13.48 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dr Agarwal’s Health Care and its competitors. Dr Agarwal’s Health Care's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal’s Health Care stock overvalued right now?
Dr Agarwal’s Health Care (BOM:544350) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Dr Agarwal’s Health Care's overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Dr Agarwal’s Health Care (BOM:544350), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dr Agarwal's Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.
17GF Score
Get the complete analysis for BOM:544350
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544350 has been successfully added to your 
